Brigitte von Brunn

542 total citations
9 papers, 405 citations indexed

About

Brigitte von Brunn is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Brigitte von Brunn has authored 9 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Brigitte von Brunn's work include SARS-CoV-2 and COVID-19 Research (4 papers), Signaling Pathways in Disease (4 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Brigitte von Brunn is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Signaling Pathways in Disease (4 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Brigitte von Brunn collaborates with scholars based in Germany, United States and Italy. Brigitte von Brunn's co-authors include Albrecht von Brunn, Yue Ma‐Lauer, Javier Carbajo-Lozoya, Christian Drosten, Miroslav Malešević, Günter Fischer, Marcel A. Müller, Sabine Hünten, Heiko Hermeking and Matthias Mann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Virus Research.

In The Last Decade

Brigitte von Brunn

8 papers receiving 402 citations

Peers

Countries citing papers authored by Brigitte von Brunn

Since Specialization

Citations

This map shows the geographic impact of Brigitte von Brunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte von Brunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte von Brunn more than expected).

Fields of papers citing papers by Brigitte von Brunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte von Brunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte von Brunn. The network helps show where Brigitte von Brunn may publish in the future.

Co-authorship network of co-authors of Brigitte von Brunn

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte von Brunn. A scholar is included among the top collaborators of Brigitte von Brunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte von Brunn. Brigitte von Brunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16 2025 ·Pathogens ·Yi Ru, Yue Ma‐Lauer, (unknown), (unknown), Brigitte von Brunn, (unknown), (unknown), Andreas Pichlmair, Susanne Pfefferle, Markus Klein, Robert Damoiseaux, Ulrich Betz, Albrecht von Brunn	1
2	Oxysterole-binding protein targeted by SARS-CoV-2 viral proteins regulates coronavirus replication 2024 ·Frontiers in Cellular and Infection Microbiology ·Yue Ma‐Lauer, (unknown), Daniela Niemeyer, Anja Richter, (unknown), Brigitte von Brunn, Yi Ru, (unknown), (unknown), Jia Liu, (unknown), (unknown), Haibo Qiu, (unknown), Elisabeth Kremmer, Heinrich Flaswinkel, Christian Drosten, Zhendong Jin, Albrecht von Brunn	6
3	Soluble uric acid inhibits β2 integrin–mediated neutrophil recruitment in innate immunity 2022 ·Blood ·Qiuyue Ma, Roland Immler, Monika Pruenster, (unknown), Chenyu Li, Albrecht von Brunn, Brigitte von Brunn, Rosina Ehmann, Roman Wölfel, (unknown), (unknown), Paola Romagnani, Ralph T. Böttcher, Markus Sperandio, Hans‐Joachim Anders, Stefanie Steiger	38
4	Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Yue Ma‐Lauer, (unknown), Brigitte von Brunn, Anne Hilgendorff, Rudolf Hatz, Jürgen Behr, Felix Hausch, Claudia A. Staab-Weijnitz, Albrecht von Brunn	7
5	Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication 2019 ·Antiviral Research ·Yue Ma‐Lauer, Yu Zheng, Miroslav Malešević, Brigitte von Brunn, Günter Fischer, Albrecht von Brunn	51
6	p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PL ^pro via E3 ubiquitin ligase RCHY1 2016 ·Proceedings of the National Academy of Sciences ·Yue Ma‐Lauer, Javier Carbajo-Lozoya, Marco Y. Hein, Marcel A. Müller, Wen Deng, Jian Lei, Benjamin Meyer, Yuri Kusov, Brigitte von Brunn, (unknown), Sabine Hünten, Christian Drosten, Heiko Hermeking, Heinrich Leonhardt, Matthias Mann, Rolf Hilgenfeld, Albrecht von Brunn	164
7	Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication 2015 ·Current Opinion in Virology ·Albrecht von Brunn, Sandra Ciesek, Brigitte von Brunn, Javier Carbajo-Lozoya	31
8	Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir 2014 ·Virus Research ·Javier Carbajo-Lozoya, Yue Ma‐Lauer, Miroslav Malešević, (unknown), (unknown), Erik Prell, Brigitte von Brunn, Doreen Muth, Thomas F. Baumert, Christian Drosten, Günter Fischer, Albrecht von Brunn	107
9	New Crown Motif of an HIV-1 V3 Loop Sequence from a Ugandan AIDS Patient 1995 ·AIDS Research and Human Retroviruses ·Albrecht von Brunn, Brigitte von Brunn, Josef Eberle, Benon Biryahwaho, R. G. Downing, Lutz Gürtler	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact